# Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis

> **NCT02762955** · PHASE3 · COMPLETED · sponsor: **Biocad** · enrollment: 344 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **BIOLOGICAL:** BCD-057
- **BIOLOGICAL:** Humira®

## Key facts

- **NCT ID:** NCT02762955
- **Lead sponsor:** Biocad
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2017-12
- **Final completion:** 2018-10-15
- **Target enrollment:** 344 (ACTUAL)
- **Last updated:** 2021-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02762955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02762955, "Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02762955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*